Ahlem; Clarence N.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ahlem; Clarence N..The latest application filed is for "treatment of ocular diseases".
- Ahlem; Clarence N. - San Diego CA US
- Ahlem; Clarence N. - La Jolla CA
- Ahlem; Clarence N. - Bellevue WA
| Patent | Date |
|---|---|
| Treatment of Ocular Diseases App 20140010806 - Frincke; James M. ; et al. | 2014-01-09 |
| Drug screening and treatment methods Grant 8,217,025 - Flores-Riveros , et al. July 10, 2 | 2012-07-10 |
| Pharmaceutical compositions 3 Grant 7,723,532 - Frincke , et al. May 25, 2 | 2010-05-25 |
| Therapeutic treatment methods Grant 7,547,687 - Reading , et al. June 16, 2 | 2009-06-16 |
| Pharmaceutical Compositions 3 App 20080176824 - Frincke; James M. ; et al. | 2008-07-24 |
| Pharmaceutical compositions and treatment methods Grant 7,396,827 - Ahlem , et al. July 8, 2 | 2008-07-08 |
| Drug Identification and Treatment Method App 20080153792 - Frincke; James M. ; et al. | 2008-06-26 |
| Drug Identification and Treatment Method App 20080153797 - Frincke; James M. ; et al. | 2008-06-26 |
| Drug Screening and Treatment Methods App 20080146532 - Flores-Riveros; Jaime ; et al. | 2008-06-19 |
| Cystic fibrosis treatment methods App 20080090791 - Reading; Christopher L. ; et al. | 2008-04-17 |
| Disease treatment methods App 20080085873 - Reading; Christopher L. ; et al. | 2008-04-10 |
| Metabolic Disease Treatments App 20080015174 - Reading; Christopher L. ; et al. | 2008-01-17 |
| Therapeutic Treatment Methods App 20070275938 - Reading; Christopher L. ; et al. | 2007-11-29 |
| Formulations and Treatment Methods App 20070275936 - Ahlem; Clarence N. ; et al. | 2007-11-29 |
| Therapeutic Treatment Methods App 20070275937 - Reading; Christopher L. ; et al. | 2007-11-29 |
| Asthma Treatment Methods App 20070265236 - Reading; Christopher L. ; et al. | 2007-11-15 |
| Sepsis Treatment Methods App 20070213309 - Reading; Christopher L. ; et al. | 2007-09-13 |
| Pharmaceutical treatments and compositions App 20070129282 - Ahlem; Clarence N. ; et al. | 2007-06-07 |
| Treatment screening methods App 20060088473 - Dowding; Charles ; et al. | 2006-04-27 |
| Compositions and treatment methods App 20060079492 - Ahlem; Clarence N. ; et al. | 2006-04-13 |
| Treatment screening methods App 20060073099 - Frincke; James M. ; et al. | 2006-04-06 |
| Therapeutic treatment methods 2 App 20050101581 - Reading, Christopher L. ; et al. | 2005-05-12 |
| Bifunctional boronic compound complexing reagents and complexes Grant 6,870,065 - Ahlem , et al. March 22, 2 | 2005-03-22 |
| Therapeutic treatment methods App 20040138187 - Reading, Christopher L. ; et al. | 2004-07-15 |
| Pharmaceutical compositions and treatment methods App 20040043973 - Ahlem, Clarence N. ; et al. | 2004-03-04 |
| Bifunctional boronic compound complexing reagents and complexes App 20030105280 - Ahlem, Clarence N. ; et al. | 2003-06-05 |
| Blood cell deficiency treatment method App 20030083231 - Ahlem, Clarence N. ; et al. | 2003-05-01 |
| Immune modulation method using steroid compounds App 20030060425 - Ahlem, Clarence N. ; et al. | 2003-03-27 |
| Bifunctional boronic compound complexing reagents and complexes Grant 6,414,122 - Ahlem , et al. July 2, 2 | 2002-07-02 |
| Bifunctional boronic compound complexing reagents and complexes Grant 6,156,884 - Ahlem , et al. December 5, 2 | 2000-12-05 |
| Fluorescent labeling reagents Grant 5,650,512 - Ahlem , et al. July 22, 1 | 1997-07-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 